 |
|
|
| |
HIV NRTI BMS-986001 in Antiretroviral-Naïve Subjects:
Evaluation of Bone and Metabolic Safety Data Through Week 48
|
| |
| |
Reported by Jules Levin
ICAAC 2014 Wash DC Sept 5-9
GA McComsey,1 SK Gupta,2 C Orrell,3 A Avihingsanon,4 O Osiyemi,5 D Stock,6 N Ray,7 SR Joshi,6 GJ Hanna,7M Lataillade,6 for the AI467003 study team
1. Case Western Reserve University, Cleveland, OH, USA; 2. Indiana University School of Medicine, Indianapolis, IN, USA; 3. Desmond Tutu HIV Foundation, Cape Town, South Africa; 4. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand;
5. Triple O Research Institute, PA, West Palm Beach, FL, USA; 6. Bristol-Myers Squibb, Wallingford, CT, USA; 7. Bristol-Myers Squibb, Princeton, NJ, USA.
|
| |
|
|
|
|
|
